Form 4: Thermo Fisher Scientific Director Dion J. Weisler Reports Changes in Beneficial Ownership
SEC Form 4 Filing
Director Dion J. Weisler reports changes in beneficial ownership of Thermo Fisher Scientific stock, including acquisitions and disposals.
Summary
- On May 21, 2025, Dion J. Weisler, a director of Thermo Fisher Scientific Inc., reported changes in their beneficial ownership of the company's common stock.
- Weisler disposed of 53.529 shares at a price of $398.28.
- Weisler also acquired 565 shares at a price of $0.
- Following these transactions, Weisler directly owns 5,027.671 shares of Thermo Fisher Scientific common stock.
Sentiment
Score: 5
Explanation: The sentiment is neutral. The filing reports both a disposal and an acquisition of shares, making it difficult to definitively assess the director's sentiment. Further context is needed.
Positives
- The acquisition of 565 shares, even at $0, indicates a continued investment in the company.
Negatives
- The disposal of 53.529 shares could be interpreted negatively, although the reason for disposal is not specified.
Risks
- The Form 4 filing itself doesn't inherently indicate risks, but monitoring insider transactions is crucial for assessing potential shifts in sentiment or strategy.
Industry Context
Form 4 filings are a routine part of regulatory compliance for corporate insiders and are closely watched by investors for signals about company prospects. It's important to consider these transactions in the context of overall market conditions and company performance.
Comparison to Industry Standards
- Comparing Weisler's transactions to those of other directors or executives at Thermo Fisher Scientific, or at comparable companies like Danaher or Agilent, could provide additional context.
- Analyzing the frequency and size of insider transactions across the industry can help determine if these actions are typical or indicative of a specific trend.
Key Dates
| Date | Description |
|---|---|
| 05/21/2025 | Date of the reported transactions (disposal and acquisition of common stock). |
| 05/22/2025 | Date of signature on the Form 4 filing. |
Keywords
Thermo Fisher Scientific, Dion J. Weisler, beneficial ownership, Form 4, insider trading, stock, acquisition, disposal
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.